Walder Wyss has acted as advisor to Sleepiz in the completion of its CHF 4.4 million Series A financing round. The newly raised capital will support Sleepiz expansion of its portfolio to chronic respiratory disease monitoring.
Tags :Leandro Schafer
Walder Wyss advised the buyer of a majority stake in Fedafin AG, a FINMA recognized rating agency with a broad market base and a provider of issuer and issue ratings for Swiss companies and municipalities.